Researchers at Osaka University have found that patients with steatotic liver disease who have high levels of growth differentiation factor 15 (GDF15) in their blood are more likely to develop liver cancer. By combining blood GDF15 levels with liver stiffness indicators, it is possible to more effectively identify patients at high risk of developing liver cancer, experiencing liver deterioration, and having poor outcomes.

<plone.namedfile.file.NamedBlobImage object at 0x7f18469dfc80 oid 0x605537 in <Connection at 7f1869fa4bb0>>

2024-06-18

life_sciences_medicine

{'items': [{'key': '5b88r', 'term': '', 'description': {'blocks': [{'key': 'fis6c', 'text': '', 'type': 'unstyled', 'depth': 0, 'inlineStyleRanges': [], 'entityRanges': [], 'data': {}}], 'entityMap': {}}}]}

['med', 'ouh']

['Shusuke Kumazaki', 'Hayato Hikita', 'Tetsuo Takehara']